A new strategy to counter allergy.
Kinet
Jean-Pierre
JP
Beth Israel Deaconess Medical Center, Harvard University, Boston, USA.
D000818:Animals; D002415:Cats; D006023:Glycoproteins / Q000276:immunology*; D006801:Humans; D006967:Hypersensitivity / Q000276:immunology* / Q000628:therapy; D007073:Immunoglobulin E / Q000276:immunology; D007074:Immunoglobulin G / Q000276:immunology; D017452:Receptors, IgG / Q000276:immunology*; D011993:Recombinant Fusion Proteins / Q000276:immunology* / Q000494:pharmacology*; D014612:Vaccines / Q000276:immunology* / Q000627:therapeutic use
C489017:FCGR1A protein, human; D006023:Glycoproteins; D007074:Immunoglobulin G; D017452:Receptors, IgG; D011993:Recombinant Fusion Proteins; D014612:Vaccines; D007073:Immunoglobulin E; C059296:Fel d 1 protein, Felis domesticus